MB 1
BULLETS
Free CME
Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 215086

ACE Inhibitors Introduction Clinical use QID: 215086 (M1.OMB.1)
In scope icon M 4 A
QID 215086 (Type "215086" in App Search)
A 62-year-old man presents for cardiology follow-up 4 weeks after suffering a myocardial infarction. He was treated emergently with cardiac catheterization and discharged on a number of new medications. His past medical history is significant for hypertension and diabetes, but he was not taking any medications prior to the myocardial infarction. At this visit, his laboratory values are as follows:

Serum:
Na+: 133 mEq/L
Cl-: 107 mEq/L
K+: 5.2 mEq/L
HCO3-: 16 mEq/L
BUN: 21 mg/dL
Glucose: 147 mg/dL
Creatinine: 1.2 mg/dL

The medication that is most likely responsible for these findings primarily improves outcomes after myocardial infarction through which of the following mechanisms?
Type in at least one full word to see suggestions list